Innovative Growth Capital (IGC) is a venture capital fund that says it is the first “Reverse VC™” fund, focused on aligning corporate demand with startup capabilities and accelerating commercialization for early-stage companies. It targets U.S.-based startups in healthcare, climate, and AI, with emphasis on areas such as neuroscience and neurotechnology, energy transition and climate resilience, and AI, data science, advanced computing, autonomy, sensing, and dual-use commercial and defense technologies. IGC says it works with founders to align products to corporate demand, accelerate early revenue and strategic validation, and design commercialization and exit pathways; it also works with corporates seeking strategic alignment, technology optionality, and acquisition vectors. The website does not identify named founders, executives, fundraising rounds, amounts, lead investors, or a verified headquarters city, so those details are omitted.